GREENWOOD VILLAGE, Colo.--(BUSINESS WIRE)--LifeVantage Corporation (OTCBB: LFVN), the maker of Protandim (www.protandim.com), announced a second patent was awarded on June 10, 2008 for its Protandim® antioxidant therapy product. Protandim is clinically proven to slow the progressive rate of aging by reducing oxidative stress, which is a key factor in aging. Researchers believe that Protandim’s unique ability to reduce aging factors at the cellular level will play a pivotal role in helping consumers age gracefully. The newly issued patent is entitled, "Preparation of Compositions to Alleviate Inflammation and Oxidative Stress in a Mammal."
